Sort   by:  
 Page size 
ProteomicsPancreatic ductal adenocarcinoma (PDAC) ubiquitination profiling reveals specific prognostic and theranostic markers.
The project was aimed at identifying diGlycine (diGly) conjugated peptides obtained from sixty PDACs' patients' derived xenografs (PDXs) then to identify potential diGLy profiles that could be used as prognosis markers of the aggressiveness of the tumour and overall survival of patients as well as t...
ORGANISM(S): Homo sapiens (Human) 
2023-07-20 | PXD030011 | Pride
Theranostic markers. Ubiquitinome Digly peptide profiling Prognostic markers Lc-msms Pdac 
UnknownPancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers.
Not available
S-EPMC10244909 | biostudies-literature
UnknownTheranostic markers for personalized therapy of spider phobia: Methods of a bicentric external cross-validation machine learning approach.
Not available
S-EPMC7301283 | biostudies-literature
UnknownIn Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer.
Not available
S-EPMC11507984 | biostudies-literature
UnknownTheranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers.
Not available
S-EPMC12617286 | biostudies-literature
UnknownTargeted Theranostic Nanoparticles for Brain Tumor Treatment.
Not available
S-EPMC6321593 | biostudies-literature
UnknownTheranostic Biomarkers for Schizophrenia.
Not available
S-EPMC5412319 | biostudies-literature
Unknown3D-Printed Biodegradable Microswimmer for Theranostic Cargo Delivery and Release.
Not available
S-EPMC6728090 | biostudies-literature
UnknownMiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer.
Not available
S-EPMC5288379 | biostudies-literature
TranscriptomicsGenotyping by array of 108 clear cell renal cell carcinoma
A Cartes d'Identite des Tumeurs (CIT) project from the french Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net); Selecting patients with metastatic clear-cell renal cell carcinoma (m-ccRCC) who might benefit from treatment with targeted tyrosine kinase inhibitors (TKIs) is a challenge. ...
ORGANISM(S): Homo sapiens 
2015-01-27 | E-MTAB-3269 | biostudies-arrayexpress
Sort   by:  
 Page size